Phenotypic analysis of retinal leukocyte infiltration during combined cyclosporin a and nasal antigen administration of retinal antigens: delay and inhibition of macrophage and granulocyte infiltration

References

• Dick A D. Experimental approaches to specific immunotherapies in autoimmune disease: future treatment of endogenous posterior uveitis?. Br J Ophthalmol. 1995; 79: 81–88
   PubMed Web of Science ®Google Scholar
• Isaacs J D. Immunoadhesins for immunomodulation of autoimmune and rheumatic disease. Br J Rheumatol, in press
   Google Scholar
• Vrabec T R, Gregerson D S, Dua H S, Donoso L A. Inhibition of experimental autoimmune uveoretinitis by oral administration of S-Ag and synthetic peptides. Autoimmunity 1992; 12: 175–184
   PubMed Web of Science ®Google Scholar
• Nussenblatt R B, Caspi R R, Mahdi R, Chan C C, Roberge F, Lider O, et al. Inhibition of S-Ag induced experimental autoimmune uveoretinitis by oral induction of tolerance with S-Ag. J Immunol 1990; 144: 1689–1695
   PubMed Web of Science ®Google Scholar
• Lider O, Santos L MB, Le C YS, Higgins P J, Weiner H L. Suppression of EAE by oral administration of myelin basic protein: suppression of the disease and in vitro immune responses is mediated by antigenspecific CD8+cells. J Immunol 1988; 142: 1748–1753
   Web of Science ®Google Scholar
• Dick A D, Cheng Y F, McKinnon A, Liversidge J, Forrester J V. Nasal administration of retinal antigens suppresses the inflammatory response in experimental allergic uveoretinitis: A preliminary report of intranasal induction of tolerance with retinal antigens. Br J Ophthalmol 1993; 77: 171–175
   PubMed Web of Science ®Google Scholar
• Dick A D, Cheng Y F, Liversidge J, Forrester J V. Intranasal administration of retinal antigens suppresses retinal antigen-induced experimental autoimmune uveoretinitis. Immunology 1994; 82: 625–631
   PubMed Web of Science ®Google Scholar
• Laliotou B, Liveridge J, Forrester J V, Dick A D. Interphotoreceptor retinoid binding protein (IRBP) is a potent tolerogen in Lewis rat: Suppression of experimental autoimmune uveoretinitis (EAU) is retinal antigen specific. Br J Ophthalmol. 1997; 81: 1–7
   PubMed Web of Science ®Google Scholar
• Chen Y, Inobe J I, Marks R, Gonnella P, Kuchroo V K, Weiner H L. Peripheral deletion of antigen-reactive T cells in oral tolerance. Nature 1995; 376: 177–180
   PubMed Web of Science ®Google Scholar
• Melamed D, Friedman A. Direct evidence for anergy in T lymphocytes tolerised by oral administration of ovalbumin. Eur J Immunol 1993; 23: 935–942
   PubMed Web of Science ®Google Scholar
• Khoury S J, Hancock W W, Weiner H L. Oral tolerance to myelin basic protein and natural recovery from experimental autoimmune encephalomyelitis are associated with downregulation of inflammatory cytokines and differential upregulation of transforming growth factor beta, interleukin 4, and prostaglandin E expression in the brain. J Exp Med 1992; 176: 1355–1364
   PubMed Web of Science ®Google Scholar
• Gregerson D S, Obritsch W F, Donoso L A. Oral tolerance in Experimental Autoimmune Uveoretinitis: Distinct mechanisms of resistance are induced by low dose vs high dose feeding protocols. J Immunol 1993; 151(10)5751–5761
   PubMed Web of Science ®Google Scholar
• Weiner H L, Mackin G A, Matsui M, Orav E J, Khoury S J, Dawson D M, et al. Double-blind pilot trial of oral tolerisation with myelin antigens in multiple sclerosis. Science 1993; 259: 1321–1323
   PubMed Web of Science ®Google Scholar
• Chen Y, Inobe J I, Kuchroo V K, Baron J L, Janeway C A, Jr, Weiner H L. Oral tolerance in myelin basic protein T cell receptor transgenic mice: suppression of autoimmune encephalomyelitis and dose dependent induction of regulatory cells. Proc Natl Acad Sci (USA) 1996; 93: 338–391
   Web of Science ®Google Scholar
• Williams R O, Mason L J, Feldmann M, Maini R N. Synergy between anti-CD4 and anti-tumour necrosis factor in the amelioration of established collagen-induced arthritis. Proc Natl Acad Sci USA 1994; 91: 2762–2766, 00
   PubMed Web of Science ®Google Scholar
• Lockwood C M, Thiru S, Isaacs J D, Hale G, Waldmann H. Long term remission of intractable systemic vasculitis and monoclonal antibody therapy. Lancet 1993; 341: 1620–1622
   PubMed Web of Science ®Google Scholar
• Kreutzer B, Laliotou B, Cheng Y F, Liversidge J, Forrester J V, Dick A D. Nasal antigen administration maintains immunosuppression of uveoretinitis in cyclosporin A-treated Lewis rats: future treatment of endogenous posterior uveoretinitis?. Eye, In press
   Google Scholar
• Dick A D, Cheng Y F, Liversidge J, Forrester J V. Immunomodulation of experimental autoimmune uveoretinitis: a mode of tolerance induction with retina antigens. Eye 1994; 8: 52–29
   PubMed Web of Science ®Google Scholar
• Dick A D, McMenamin P G, Korner H, Scallon B, Ghrayeb J, Forrester J V, Sedgwick J D. Inhibition of tumour necrosis factor activity minimises target organ damage in experimental autoimmune uveoretinitis despite quantitatively normal activated T cell traffic to the retina. Eur J Immunol 1996; 26: 1018–1025
   PubMed Web of Science ®Google Scholar
• Dick A D, Ford A L, Forrester J V, Sedgwick J D. Flow cytometric identification of a minority population of MHC class II positive cells in the normal rat retina distinct from CD45lowCD11b/c+CD4low parenchymal microglia. Br J Ophthalmol 1995; 75: 834–840
   Google Scholar
• Ford A L, Goodsall A l, Hickey W F, Sedgwick J D. Normal adult ramified microglia separated from other CNS macrophages by flow cytometric sorting: phenotypic differences defined and direct ex vivo antigen presentation to myelin basic proteinreactive CD4+ T cells compared. J Immunol 1995; 154: 4309–4321
   PubMed Web of Science ®Google Scholar
• Sedgwick J, Brostoff S, Mason D. Experimental allergic encephalomyelitis in the absence of a classical delayed type hypersensitivity reaction. Severe paralytic disease correlates with the presence of interleukin 2 receptor-positive cells infiltrating the central nervous tissue. J Exp Med 1987; 165: 1058–1075
   PubMed Web of Science ®Google Scholar
• Cash E, Minty A, Ferrara P, Caput D, Frazelizi D, Rott O. Macrophage-inactivating IL-13 suppresses autoimmune encephalomyelitis in rats. J Immunol 1994; 153: 4258–65
   PubMed Web of Science ®Google Scholar
• Ahuja V, Miller S E, Howell D N. Identification of two subpopulations of rat monocytes expressing disparate molecular forms and quantities of CD43. Cell Immunol 1995; 163: 59–72
   PubMed Web of Science ®Google Scholar
• Garside P, Steel M, Liew F Y, Mowat A M. CD4+ but not CD8+T cells are required for the induction of oral tolerance. Int Immunol 1995; 7: 501–504
   PubMed Web of Science ®Google Scholar
• Rizzo L V, Miller-Rivero N E, Chan C-C, Wiggert B, Nussenblatt R B, Caspi R R. Interleukin-2 treatment potentiates induction of oral tolerance in a murine model of autoimmunity. J Clin Invest 1994; 94: 1668–1672
   PubMed Web of Science ®Google Scholar
• Granelli-Piperno A. In situ hybridisation for interleukin 2 and interleukin 2 receptor mRNA in T cells activated in the presence and absence of CsA. J Exp Med 1988; 5: 1649–58
   Google Scholar
• Huitinga I, van Rooijen N, Groot C JA, Uitdehaag B MJ, Dijkstra C D. Suppression of experimental allergic encephalomyelitis in Lewis rats after elimination of macrophages. J Exp Med 1990; 172: 1025–1033
   PubMed Web of Science ®Google Scholar
• Caspi R R, Chan C C, Fujino Y, Najafian F, Grover S, Hansen C T, Wilder R L. Recruitment of antigennonspecific cell plays a pivotal role in the pathogenesis of a T cell mediated organ-specific autoimmune uveoretinitis. J Neuroimmunol 1993; 47: 177–185
   PubMed Web of Science ®Google Scholar